BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 27521149)

  • 1. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis.
    Guy A; Bidet A; Ling C; Caumont C; Boureau L; Viallard JF; Parrens M
    Virchows Arch; 2021 Oct; 479(4):755-764. PubMed ID: 33934231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.
    Song MK; Park BB; Uhm JE
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
    Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
    Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-needle aspiration diagnosis of clonal extramedullary hematopoiesis in a case of myeloproliferative neoplasm.
    Shponka V; Bone K; Nomani L; Hunt B
    Diagn Cytopathol; 2022 Feb; 50(2):E43-E46. PubMed ID: 34617678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
    Khanlari M; Wang X; Loghavi S; Wang SA; Li S; Thakral B; Bueso-Ramos CE; Yin CC; Kanagal-Shamanna R; Khoury JD; Patel KP; Popat UR; Medeiros LJ; Konoplev S
    Ann Diagn Pathol; 2022 Feb; 56():151860. PubMed ID: 34823075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiology.
    Pizzi M; Fuligni F; Santoro L; Sabattini E; Ichino M; De Vito R; Zucchetta P; Colombatti R; Sainati L; Gamba P; Alaggio R
    Hum Pathol; 2017 Feb; 60():95-103. PubMed ID: 27771375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
    Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
    J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation.
    Hart C; Klatt S; Barop J; Müller G; Schelker R; Holler E; Huber E; Herr W; Grassinger J
    Haematologica; 2016 Nov; 101(11):1407-1416. PubMed ID: 27662011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis.
    Miwa Y; Hayashi T; Suzuki S; Abe S; Onishi I; Kirimura S; Kitagawa M; Kurata M
    Pathology; 2013 Jun; 45(4):408-16. PubMed ID: 23619587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition.
    Prakash S; Hoffman R; Barouk S; Wang YL; Knowles DM; Orazi A
    Mod Pathol; 2012 Jun; 25(6):815-27. PubMed ID: 22388763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
    Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
    Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
    Selicean SE; Tomuleasa C; Grewal R; Almeida-Porada G; Berindan-Neagoe I
    Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma.
    O'Keane JC; Wolf BC; Neiman RS
    Cancer; 1989 Apr; 63(8):1539-43. PubMed ID: 2924261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary hematopoiesis in an inguinal lymph node: an unusual presentation of primary myelofibrosis.
    Yaqoob N; Mansoor N; Naveed H; Jamal S
    World J Surg Oncol; 2022 Jun; 20(1):186. PubMed ID: 35676715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders.
    O'Malley DP; Kim YS; Perkins SL; Baldridge L; Juliar BE; Orazi A
    Mod Pathol; 2005 Dec; 18(12):1550-61. PubMed ID: 16118626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
    Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
    J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of immunomorphometric assessment of angiogenesis to distinguish primary versus secondary myelofibrosis.
    Sharma P; Pati HP; Mishra PC; Dinda AK; Gupta R; Sharma A; Jacob TG
    Anal Quant Cytol Histol; 2011 Aug; 33(4):236-44. PubMed ID: 21980629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.